• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可注射的基于镁双膦酸盐金属有机框架的骨粘合剂可防止骨质疏松性骨折修复过程中出现过度纤维化。

Injectable magnesium-bisphosphonate MOF-based bone adhesive prevents excessive fibrosis for osteoporotic fracture repair.

作者信息

Xiao Tianhua, Gong Zunlei, Duan Dongming, Yu Hui, Liu Song, Jiang Yuhe, Xing Xudan, Wu Zenghui, Wang Le, Yang Xuebin B, Tronci Giuseppe, Ning Chengyun, Tan Guoxin, Zhou Lei

机构信息

School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, China.

Department of Orthopaedic Surgery, Guangzhou Key Laboratory of Spine Disease Prevention and Treatment, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

出版信息

Nat Commun. 2025 Jul 1;16(1):5679. doi: 10.1038/s41467-025-60853-8.

DOI:10.1038/s41467-025-60853-8
PMID:40593608
Abstract

Current treatments for osteoporotic fractures primarily target bone-resorbing osteoclasts, but they often fail to address fibrosis-a buildup of fibrous tissue that disrupts bone healing. This fibrosis is frequently triggered by bisphosphonates, which, while effective in reducing bone loss, also activate fibroblasts and impair callus formation. Here we show that an injectable hydrogel bone adhesive composed of magnesium-alendronate metal-organic frameworks (Mg-ALN MOF) embedded in a gelatin/dialdehyde starch network can simultaneously suppress bone resorption and reduce fibrosis. The Mg-ALN MOF adhesive binds firmly to irregular bone surfaces and degrades under acidic osteoporotic conditions, gradually releasing Mg ions. These ions competitively bind to sclerostin (SOST), thereby interrupting the SOST/TGF-β signaling pathway that promotes fibroblast activation and abnormal collagen deposition. This dual-action mechanism significantly enhances fracture healing, resulting in a 27.8% improvement in flexural strength. Our findings suggest a promising therapeutic strategy that combines mechanical support with targeted regulation of both bone resorption and pathological fibrosis.

摘要

目前针对骨质疏松性骨折的治疗主要针对骨吸收破骨细胞,但往往无法解决纤维化问题——纤维化是一种纤维组织堆积,会干扰骨愈合。这种纤维化通常由双膦酸盐引发,双膦酸盐虽然能有效减少骨质流失,但也会激活成纤维细胞并损害骨痂形成。在此,我们展示了一种可注射水凝胶骨粘合剂,它由嵌入明胶/二醛淀粉网络中的阿仑膦酸镁金属有机框架(Mg-ALN MOF)组成,能够同时抑制骨吸收并减少纤维化。Mg-ALN MOF粘合剂牢固地结合在不规则骨表面,并在酸性骨质疏松条件下降解,逐渐释放镁离子。这些离子与硬化蛋白(SOST)竞争性结合,从而中断促进成纤维细胞激活和异常胶原蛋白沉积的SOST/TGF-β信号通路。这种双作用机制显著增强骨折愈合,使弯曲强度提高27.8%。我们的研究结果表明了一种有前景的治疗策略,即将机械支撑与对骨吸收和病理性纤维化的靶向调节相结合。

相似文献

1
Injectable magnesium-bisphosphonate MOF-based bone adhesive prevents excessive fibrosis for osteoporotic fracture repair.可注射的基于镁双膦酸盐金属有机框架的骨粘合剂可防止骨质疏松性骨折修复过程中出现过度纤维化。
Nat Commun. 2025 Jul 1;16(1):5679. doi: 10.1038/s41467-025-60853-8.
2
Treatment for osteoporosis in people with beta-thalassaemia.β-地中海贫血患者骨质疏松的治疗。
Cochrane Database Syst Rev. 2023 May 9;5(5):CD010429. doi: 10.1002/14651858.CD010429.pub3.
3
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.阿仑膦酸钠用于绝经后妇女骨质疏松性骨折的一级和二级预防。
Cochrane Database Syst Rev. 2025 Jan 27;1(1):CD001155. doi: 10.1002/14651858.CD001155.pub3.
4
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.利塞膦酸钠用于绝经后妇女骨质疏松性骨折的一级和二级预防。
Cochrane Database Syst Rev. 2022 May 3;5(5):CD004523. doi: 10.1002/14651858.CD004523.pub4.
5
Bisphosphonate therapy for osteogenesis imperfecta.用于成骨不全症的双膦酸盐治疗
Cochrane Database Syst Rev. 2016 Oct 19;10(10):CD005088. doi: 10.1002/14651858.CD005088.pub4.
6
Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126.低氧骨髓间充质干细胞来源的外泌体通过转移 miR-126 促进骨骨折愈合。
Acta Biomater. 2020 Feb;103:196-212. doi: 10.1016/j.actbio.2019.12.020. Epub 2019 Dec 17.
7
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003474. doi: 10.1002/14651858.CD003474.pub2.
8
Bisphosphonates for steroid-induced osteoporosis.双膦酸盐用于治疗类固醇诱导的骨质疏松症。
Cochrane Database Syst Rev. 2016 Oct 5;10(10):CD001347. doi: 10.1002/14651858.CD001347.pub2.
9
Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis.用于减少早期和局部晚期乳腺癌女性骨丢失的骨修饰剂:一项网络荟萃分析。
Cochrane Database Syst Rev. 2024 Jul 9;7(7):CD013451. doi: 10.1002/14651858.CD013451.pub2.
10
Treatment for osteoporosis in people with ß-thalassaemia.β地中海贫血患者骨质疏松症的治疗
Cochrane Database Syst Rev. 2016 Mar 10;3:CD010429. doi: 10.1002/14651858.CD010429.pub2.

本文引用的文献

1
High-Strength Gelatin Hydrogel Scaffold with Drug Loading Remodels the Inflammatory Microenvironment to Enhance Osteoporotic Bone Repair.载药高强度明胶水凝胶支架重塑炎症微环境以增强骨质疏松性骨修复
Adv Mater. 2025 Apr;37(13):e2501051. doi: 10.1002/adma.202501051. Epub 2025 Feb 19.
2
Determination of bisphosphonate properties in terms of bioavailability, bone affinity, and cytotoxicity.测定生物利用度、骨亲和力和细胞毒性方面的双膦酸盐特性。
Pharmacol Rep. 2024 Oct;76(5):1160-1173. doi: 10.1007/s43440-024-00624-2. Epub 2024 Jul 15.
3
The role of magnesium in the pathogenesis of osteoporosis.
镁在骨质疏松症发病机制中的作用。
Front Endocrinol (Lausanne). 2024 Jun 6;15:1406248. doi: 10.3389/fendo.2024.1406248. eCollection 2024.
4
Nutrient-delivery and metabolism reactivation therapy for melanoma.营养输送和代谢激活疗法治疗黑色素瘤。
Nat Nanotechnol. 2024 Sep;19(9):1399-1408. doi: 10.1038/s41565-024-01690-6. Epub 2024 Jun 11.
5
Metal-Drug Coordination Nanoparticles and Hydrogels for Enhanced Delivery.金属-药物配位纳米粒子和水凝胶用于增强递药。
Adv Mater. 2024 Jun;36(26):e2404053. doi: 10.1002/adma.202404053. Epub 2024 Apr 18.
6
Bisphosphonates for osteoporosis: from bench to clinic.用于治疗骨质疏松症的双膦酸盐:从实验室到临床
J Clin Invest. 2024 Mar 15;134(6):e179942. doi: 10.1172/JCI179942.
7
Degradable Nanohydroxyapatite-Reinforced Superglue for Rapid Bone Fixation and Promoted Osteogenesis.可降解纳米羟基磷灰石增强型超级胶水,用于快速固定骨骼和促进成骨。
ACS Nano. 2024 Mar 19;18(11):8517-8530. doi: 10.1021/acsnano.4c01214. Epub 2024 Mar 5.
8
Osteoporosis.骨质疏松症。
Ann Intern Med. 2024 Jan;177(1):ITC1-ITC16. doi: 10.7326/AITC202401160. Epub 2024 Jan 9.
9
Magnetic Aggregation-Induced Bone-Targeting Nanocarrier with Effects of Piezo1 Activation and Osteogenic-Angiogenic Coupling for Osteoporotic Bone Repair.磁聚集诱导的骨靶向纳米载体对骨质疏松性骨修复的作用:激活Piezo1并促进成骨-血管生成耦合
Adv Mater. 2024 Mar;36(13):e2312081. doi: 10.1002/adma.202312081. Epub 2023 Dec 26.
10
Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture.通过内分泌信号的肌肉-骨骼相互作用以及骨质疏松性肌少症相关骨折的潜在靶点
J Orthop Translat. 2023 Nov 5;43:36-46. doi: 10.1016/j.jot.2023.09.007. eCollection 2023 Nov.